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Background: The -MSH peptide is essential in regulating food intake and energy expenditure.
Results: ER stress induced by obesity reduces -MSH, accumulates POMC, and decreases the enzyme PC2.
Conclusion: There is a direct link between obesity and ER stress, resulting in altered POMC processing.
Significance:These studies bring a new perspective to how ER stress can regulate energy balance by altering POMCprocessing.
It was shown previously that abnormal prohormone process-
ing or inactive proconverting enzymes that are responsible for
this processing cause profound obesity. Our laboratory demon-
strated earlier that in the diet-induced obesity (DIO) state, the
appetite-suppressing neuropeptide -melanocyte-stimulating
hormone (-MSH) is reduced, yet the mRNA of its precursor
protein proopiomelanocortin (POMC) remained unaltered. It
was also shown that the DIO condition promotes the develop-
ment of endoplasmic reticulum (ER) stress and leptin resistance.
In the current study, using an in vivo model combined with in
vitro experiments, we demonstrate that obesity-induced ER
stress obstructs the post-translational processing of POMC by
decreasing proconverting enzyme2,which catalyzes the conver-
sion of adrenocorticotropin to -MSH, thereby decreasing
-MSH peptide production. This novel mechanism of ER stress
affecting POMCprocessing inDIOhighlights the importance of
ER stress in regulating central energy balance in obesity.
Severe obesity is associated with cardiovascular disease and
type-2 diabetes among other co-morbidities. Despite the great
progress made in this field, our limited understanding of this
condition has been disappointing. In the brain, the hypotha-
lamic arcuate (ARC)3 nucleus controls energy balance and body
weight through the production of anorexigenic and orexigenic
neuropeptides. The ARC-derived peptide, -melanocyte stim-
ulating hormone (-MSH), is released by the central melano-
cortin system and plays a major anorexigenic role in the regu-
lation of feeding and energy expenditure (1). -MSH is
generated from its prohormone, proopiomelanocortin (POMC),
through a series of tightly regulated post-translational process-
ing modifications. This process is conducted by two members
of the family of prohormone convertases, prohormone conver-
tase 1 and 2 (PC1 and PC2), and other processing enzymes
while transported through the regulated secretory pathway (2,
3) and axon terminals. It has been shown in several landmark
studies that abnormal processing for certain prohormones
causes profound obesity. An early study showed that a patient
with a compound heterozygous mutation in the PC1 gene
resulted in the production of nonfunctional PC1 with severe
childhood obesity (4). An analogous obese condition was found
in a patient with a defect in POMC processing (5). This condi-
tion was reproduced in a mouse model of PC1 deficiency gen-
erated by randommutagenesis (6). Another example is the well
known Cpefat/Cpefat mouse with a point mutation in the car-
boxyl peptidase (cpe) gene. This fat/fatmouse is obese, diabetic,
and infertile (7, 8). Altogether, these previous studies clearly
indicate that abnormal prohormone processing in particular
prohormones causes obesity. Consistent with those observa-
tions, our previous studies (9) and studies presented here
strongly indicate that during diet-induced obesity (DIO), there
is a defect in POMC processing, including a decrease in the
synthesis of the-MSHpeptide, yet DIOdoes not affect POMC
mRNA. Along with the decrease in -MSH, we observe a sig-
nificant reduction in PC2, which catalyzes the conversion of
adrenocorticotropin (ACTH) to -MSH.
In addition to impaired prohormone processing, the DIO
state is also associated with endoplasmic reticulum (ER) stress,
which appears to regulate energy balance. When the ER
becomes stressed because of an excessive accumulation of
newly synthesized unfolded proteins, the unfolded protein
response (UPR) is activated. TheseUPRpathways act in concert
to increase ER content, expand the ER protein folding capacity,
degrade misfolded proteins, and reduce the load of new pro-
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teins entering the ER, all of which is geared toward adaptation
to resolve the protein folding defect. Early studies showed that
obesity-induced ER stress impairs insulin biosynthesis (10) in
pancreatic B cells by affecting proinsulin folding, processing,
and insulin release. In addition, hypothalamic ER stress has
been proposed as one of the possiblemechanisms inducing lep-
tin resistance and altered energy balance during obesity (11–
14). In the current study, our in vivo and in vitro data strongly
suggest that obesity-inducedER stress obstructs the post-trans-
lational processing of POMC and reduces -MSH peptide pro-
duction. In this study, we demonstrate a direct link between ER
stress and POMCprocessing in the obese state, and we demon-
strate that ER stress mediates high fat diet (HFD)-induced
changes in -MSH levels. Although changes in POMC gene
expression are extremely important in regulating energy bal-
ance, our results underscore the importance of other cellular
mechanisms, such as POMC post-translational processing, in
regulating energy balance, because we demonstrate that
-MSH decreases in DIO and with ER stress, whereas POMC
mRNA levels do not change in these two conditions.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Recombinant murine leptin was
obtained from Dr. E. Parlow (NIDDK, National Institutes of
Health, and theNationalHormone andPituitary Program,Tor-
rance, CA). Tauroursodeoxycholic acid (TUDCA) and AG490
were fromEMDMillipore. Anti-p-PERK, anti-p-eIF2, PTP1B,
pStat3, total Stat3, and SOCS3 antibodies were from Cell Sig-
naling. CPE and -actin were from Santa Cruz Biotechnology,
Inc. Rabbit anti-ObRb was from Linco Research, Inc. Anti-PC1
and PC2 were a gift from Dr. Nabil G. Seidah (Institut de
Recherches Cliniques deMontréal). Rabbit anti-ACTH anti--
MSH antibody was developed in our laboratory (15, 16). Bioti-
nylated goat anti-rabbit antibody was from Jackson Immuno-
Research Laboratories.
Animals—Male Sprague-Dawley rats (22 days old) from
Charles River Laboratories were fed a regular diet (Purina Lab
Chow, catalog no. 5001) or an HFD (Rodent Chow, catalog no.
D12492, ResearchDiets) for 12weeks. Regular diet provided 3.3
kcal/g energy (59.8% carbohydrate, 28.0% protein, and 12.1%
fat). HFD provided 5.24 kcal/g energy (20.0% carbohydrate,
20.0% protein, and 60.0% fat). We began with 12 rats/group.
However, some individuals on the HFD gain weight and fat at
the same rate as their counterparts kept on the standard diet.
These individuals are called DIO-resistant (17). DIO-resistant
animals were excluded from our studies, and thus sample sizes
for experiments ranged from eight to 10 individuals. We
recently characterized hormonal and physiological character-
istics of this rat DIOmodel (18). Food and water were available
ad libitum unless otherwise indicated. Body weights were
measuredweekly. The InstitutionalAnimalCare andUseCom-
mittee of Rhode IslandHospital/BrownUniversity approved all
of the experimental protocols and euthanasia procedures.
In Vivo Studies—Following each experiment, rats were
euthanized by decapitation. Blood was collected for further
analysis. The PVN (paraventricular nucleus) andARCwere col-
lected by microdissection and subjected to the following: acid
peptide extraction with 2 N acetic acid supplemented with a
protease inhibitor mixture to measure peptides by HPLC and
specific RIA; protein extraction with radioimmune precipita-
tion assay buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5%
sodium deoxycholate, 0.1% SDS, 1% Nonidet P-40) supple-
mented with protease inhibitor mixture for Western blot
analysis; or RNA isolation with TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions for real-time
PCR analysis. Protein concentration was determined by
the Bradford assay. RNA concentration was determined
by spectrophotometry. RNA integrity was determined using
nanochips.
To evaluate the response to fasting, lean and DIO rats were
divided into two groups. One group was fed ad libitum, and the
other was fasted for 48 h. We evaluated the response to central
leptin administration in both groups of rats by stereotaxically
implanting an icv cannula (Plastic One) 10 days before the
experiment as described previously (19). The correct place-
ment of the cannulas was verified by measurement of water
intake in response to icv injection of angiotensin II (40 ng/rat).
Fasted ratswere given icv 4l of vehicle (artificial cerebrospinal
fluid) alone or vehicle containing leptin (3.5 g/rat). All injec-
tions were performed between 09:00 and 10:30. Animals were
sacrificed 3 h later, and samples were processed as indicated
above.
To inhibit leptin signaling, animals were given 10 l icv of
vehicle (13% DMSO in artificial cerebrospinal fluid) alone or
containingAG-490 (Sigma-Aldrich; 54 nmol/rat) at 18:00. Ani-
mals were euthanized the following morning. To alleviate ER
stress, animals were given TUDCA (Calbiochem-EMD Chem-
icals). TUDCAwas diluted in saline, and the pHwas adjusted to
7.4 using NaOH to avoid toxicity. TUDCA was then injected
intraperitoneally (200 mg/kg) for 2 days. Animals were eutha-
nized 6 h postinjection on the second day, and ARC samples
were collected for RIA or Western blot analyses. Body weights
of lean and DIO rats treated with and without TUDCA were
taken immediately prior to the first TUDCA infusion and a
second time immediately prior to sacrifice. The change in body
weight due to TUDCA was measured as the percentage weight
gain (g) from the first to the second measurement. Male rats
(300 g) were used for tunicamycin or thapsigargin experiments.
Rats received DMSO (vehicle), tunicamycin (10 g), or thapsi-
gargin (10 ng) in a total of 4 l. Energy expenditure was mea-
sured using the Oxymax indirect calorimeter system (Colum-
bus Instruments, Columbus, OH) in animals that were fasted
overnight. For the thapsigargin experiment, oxygen consump-
tion was measured up to 3 h postinjection. For the TUDCA
experiment, oxygen consumption was measured overnight fol-
lowing injections.
In Vitro Studies—N43/5 cells were used because they express
POMC and PC2, and these cells have been used as an in vitro
system that mimics hypothalamic POMC neuronal physiology
(20). We also used a POMC-positive corticotropic AtT20 cell
line transfected with PC2 to measure both PC2 and -MSH
release. N43–5 and AtT20 cells were each cultured in Dulbec-
co’s modified Eagle’s medium (DMEM) containing 10% fetal
bovine serum. At 60–70% confluence, cells were washed twice
with DMEM without serum, and then DMEM containing 1%
fetal bovine serum was added. Some cells were pretreated with
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sodium 4-phenylbutyrate (PBA) (20 mM) or salubrinal (7.5 M)
for 14 h, after which 0.1 g/ml tunicamycin was added for 0, 1,
2, 3, or 4 h, or thapsigargin (100 nM) was added for 6 h. At the
end of the treatment period, cells were lysed with HEPES/KOH
buffer.
Luciferase Assays—N43/5 cells were allowed to adhere over-
night in 96-well plates. Cells were transfected using Lipo-
fectamine 2000 with the human PC2-luciferase promoter con-
struct from the human PC2 promoter (789 bp to1 bp relative
to the translation initiation codon) inserted in the pGL2-Basic
vector (21). Cells were incubatedwith both PC2 promoter (0.15
g) and a Renilla control (pRL-SV40, 0.15g; Promega) for 6 h
in antibiotic-free, serum-free medium, and then the medium
was changed to complete DMEM for overnight incubation.
Cells were then treated with tunicamycin (0.1g/ml) or vehicle
control. Luminescence of luciferase and Renilla were deter-
mined using the Dual-glo luciferase assay system (Promega),
and luminescence was read with the TopCount NXT micro-
plate luminescence counter (PerkinElmer Life Sciences).
Quantification of POMC mRNA by Real-time Quantitative
PCR—Real-time quantitative PCRprimerswere designed using
Primer3 and GenBankTM sequence data for rat POMC (acces-
sion number BC058443) and hypoxanthine phosphoribosyl-
transferase (HPRT) (accession number NM012583). Primers
were synthesized and purified by Integrated DNA Technolo-
gies (Coralville, IA). The primer sequences used were as
follows: upstream POMC, 5- AGGACCTCACCACGGAAAG-
3; downstream POMC, 5-ACTTCCGGGGATTTTCAGTC-
3; upstream HPRT, 5- GCAGACTTTGCTTTCCTTGG-3;
downstream HPRT, 5-GTCTGGCCTGTATCCAACACT-3.
Sample cDNAs were generated from total RNA using random
hexamer primers and SuperScript III reverse transcriptase
(Invitrogen). Each 25-l real-time quantitative PCR used 100
ng of cDNAas template and contained 200 nMPOMCorHPRT
primers and ABI SYBR Green PCR core reagents (Applied Bio-
systems Inc.). All reactions were performed in triplicate on an
ABI 7500 fast real-time PCR system. Standard curves for
POMC and HPRT 1 transcript levels were generated with ABI
7500 Fast System SDS Software version 1.3.1 using diluted
cDNA (100, 50, 10, 1.0, and 0.1 ng) from fed animal controls.
Averaged POMC levels normalized to HPRT1 in fast and fast
plus leptin-treated animals were compared with similar values
obtained from fed animal controls to determine relative expres-
sion levels in both tissue types (22).
HPLC Fractionation and RIA Analysis—HPLC fractionation
and RIA analysis of ACTH and -MSH have been described
previously by our laboratory (16). Briefly, samples were frac-
tionated using a Varian ProStar Gradient HPLC system
equipped with a C18 reverse phase column (Microsorb MV
300-5; Varian). Following peptide elution, samples were evap-
orated and reconstituted in RIA buffer (0.5 ml of phosphate
buffer (pH 7.4), 500 mg/liter sodium azide, 2.5 g/liter BSA).
Synthetic peptides were injected on the HPLC to determine
retention times. Predicted retention times allowed for the anal-
ysis of specific regions along the gradient for RIA. The -
MSH RIA was performed using our in-house primary anti--
MSH antiserum (1:20,000) and 5000 cpm of 125I-desacetyl
-MSH tracer. The sensitivity of the assays was11.5 pg/tube,
and the intra- and interassay variability were 5–7% and
10–11%, respectively. The -MSH assay used in this condition
can detect 100% of acetyl and desacetyl -MSH forms. The
cross-reactivity of the -MSH assay with ACTH is 22%; how-
ever, because there is a small amount of this peptide in the
samples (see results), ACTH is not found in the HPLC profile
using this assay. The ACTH RIA was performed using our in-
house anti-ACTH antiserum (1:30,000) and 5000 cpm of 125I-
ACTH tracer. The sensitivity of the assays was10.0 pg/tube,
and the intra- and interassay variability were 5–7% and
10–11%, respectively. The ACTH assay used in this assay does
not cross-react with any form of-MSH. It is important to note
that both assays cross-react with the POMC precursor, as was
demonstrated using a purified POMC (kindly donated by Dr.
AnneWhite, University of Manchester). However, because the
prohormone presented some degree of degradation, we could
not determine the percentage of cross-reactivity. Fasting glu-
cose and insulin weremeasured using a rat insulin RIA kit from
Millipore (catalog no. RI-13K) and the Quanti Chrom glucose
assay kit from Bioassay Systems (catalog no. DIGL-100).
Western Blot Analysis—For Western blot analysis, 75 g of
total ARC or PVN lysate was separated on either 6% (p-PERK),
12% (p-eIF2) or 10% (all other proteins) SDS-PAGE. Precision
Plus Protein standards were used as molecular weight markers
(Bio-Rad). After electrophoresis, proteins were electroblotted
onto PVDFmembranes for immunodetection and blockedwith
PBS in TBST (50 mM Tris, 150 mM NaCl, 0.1% Tween 20, pH
7.4). Membranes were probed overnight at 4 °C with the anti-
ObRb (1:100) or anti-SOCS3 (1:500), p-eIF2 (1:1000), p-PERK
(1:500), PTP1B (1:1000), PC1 (1:10,000), and PC2 (1:10,000)
antibodies. For POMC identification byWestern blot, we used
a combination of anti-ACTH and anti--MSH antibodies cus-
tom-made in our laboratory. These antibodies have been char-
acterized previously (23), and together they detect the POMC
precursor (31 kDa). Membranes were incubated with an HRP-
linked secondary antibody (1:5000), and immunoreactive bands
were visualized by enhanced chemiluminescence.
Statistical Analysis—Results are presented as the mean 
S.E. Statistical significance was determined by analysis of vari-
ance followed by post hoc Tukey’s test using GraphPad Prism
(version 4.0b). Differences were considered to be significant at
p 0.05.
RESULTS
The-MSHPeptide Is Lower inDIORodents, whereas POMC
mRNA Remains Unchanged—To conduct these studies, we
used the rat model because of the following. 1) Because rats
share with humans many characteristics of obesity physiology
(24), they are considered to be an excellent model to study obe-
sity physiology (17, 25, 26). 2) We have extensively character-
ized this model for energy balance studies as well as gene and
peptide analyses, including prohormone processing (16, 18, 19,
27–29). 3) POMC processing was established in the rat (30–
33), and we showed for the first time the changes in POMC
processing in the rat ARC under nutritional changes (16). 4)
Rats provide a larger source of material for peptide analysis
compared with mice. 5) Most importantly, the POMC
sequence in the rat is different from that the mouse, making it
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difficult to extrapolate a mouse model to the rat unless POMC
processing in the mouse is characterized.
Our recently published results reveal that lean andDIOmice
have similar POMCmRNA levels, yet-MSH levels were lower
in DIO mice (9), which strongly suggests that -MSH biosyn-
thesis through processing is altered in the obese state. Consis-
tent with this observation, high fat feeding in rats presented the
same profile of lower -MSH peptide with unaltered POMC
mRNA compared with lean counterparts (Fig. 1). Interestingly,
we also observed in the rat that POMC protein accumulated
during HFD feeding (Fig. 1B), suggesting that less properly
folded POMC is able to reach the Golgi complex and secretory
granules for final processing and storage but instead remained
in the ER. Therefore, two processing products of POMC,
ACTH and -MSH, were diminished (Fig. 1, C and D).
Leptin-positive Regulation on POMCmRNA Is Blunted in the
DIO State—Studies have shown that DIO animals are partially
sensitive to leptin-induced STAT3 phosphorylation in theARC
(34), and STAT3 contributes to hypothalamic POMC expres-
sion (35, 36). Because we do not see any change in POMC
mRNA in the obese state, we explored some of the factors
affecting leptin signaling in our DIO rats. Fig. 1E shows that
ObRb leptin receptor protein levels were similar between lean
and DIO ARC. Phosphorylated Stat3 is elevated in DIO (Fig.
1F). However, the negative leptin regulators suppressor of cyto-
kine signaling-3 (SOCS3) and protein-tyrosine phosphatase 1B
(PTP1B) (37) also increased in DIO compared with lean con-
trols (Fig. 1,G andH). Elevated SOCS3 and PTP1Bmay explain
why pSTAT3 is elevated in DIO, but POMC mRNA levels are
not elevated in theDIOARC (Fig. 1A and 2A). These results are
consistent with previous observations that DIO rodents
develop resistance to leptin-induced STAT3 phosphorylation
in the ARC (38).
POMC Processing Is Altered in DIO Animals—Although lep-
tin has a clear role in regulating POMC expression in the lean
animal (16), differentmechanisms appear to play a larger role in
regulating the decrease in -MSH peptide seen in the DIO.We
propose these mechanisms to be defective POMC folding and
processing. For example, we demonstrate that POMC process-
ing is altered during different nutritional states including DIO.
For example, we found thatmRNAand peptide levels of POMC
as well as levels of the POMC-derived peptides ACTH and
-MSH decrease during fasting in lean rats (16), where the
ACTH/-MSH ratio was 0.11 for fed versus 0.69 for fasted
states (16). This ratio provides a measure of the conversion of
ACTH to -MSH in the ARC, and our results demonstrate that
fasting resulted in a 6.27-fold increase in ACTH/-MSH ratio.
Administration of leptin partially reversed these effects, dem-
FIGURE1.-MSHpeptide is lower inDIO rodents,whereasPOMCmRNAremainsunchanged. Feeding rats ahigh fat diet for 12weeksgeneratedDIO (gray
bars), whereas lean controls (black bars) were kept on regular chow. A, POMC mRNA in lean and DIO ARC was measured by RT-PCR. B, Western blot analysis
depicted the accumulation of POMCprotein in the DIOARC. C, RIA of ACTH in lean andDIO rats.D, RIA of-MSH in lean andDIO rats. E, ObRb levels in lean and
DIO rat ARC as measured byWestern blot. F, Western blot of pSTAT3 over total STAT3 in the ARC of lean and DIO rats. G, SOCS3 protein levels in lean and DIO
ARCweremeasured byWestern blot.H, PTP1B protein levels in lean andDIOARCmeasured byWestern blot. n 12 lean and 8DIO. Data aremean S.E. (error
bars). *, p 0.05; **, p 0.01 versus lean control.
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onstrating that during fasting in lean animals, the biosynthesis
of POMC and its derived peptides is nutrient- and leptin-de-
pendent through STAT3 signaling (16, 36). However, this was
not the case in the DIO condition. Our current results corrob-
orate previous evidence that fasting decreases and leptin
increases POMC, ACTH, and -MSH (Fig. 2, A–C) levels in
control lean rats. In contrast, although POMC mRNA and
ACTH peptide content in DIO rats responded to fasting and
leptin to a slightly lesser degree but in a similar manner as that
in lean rats (Fig. 2, A and B), -MSH levels in DIO rats were
insensitive to either fasting or leptin administration (Fig. 2C).
These results strongly suggest that the conversion from ACTH
to -MSH is impaired in the DIO condition.
To further support our findings, we blocked STAT3 signal-
ing with the JAK2 inhibitor AG490 (Fig. 2, D and E), because
leptin activation of STAT3 is mediated by the JAK2 receptor.
icv infusedAG490 attenuatedACTH in the ARC of control and
DIO animals. Although AG490 reduced -MSH levels in lean
controls, it had no effect on-MSH levels in DIO animals. That
inhibiting leptin signaling failed to decrease -MSH suggests
that leptin may regulate -MSH levels indirectly in the DIO
condition. Collectively, the results substantiate our previous
findings that the conversion of ACTH to -MSH is impaired in
DIO.
These results led us to explore whether the POMC process-
ing cascade is impaired in DIO. PC1, PC2, and CPE regulate
POMCpost-translational processing (Fig. 3A). Fig. 3 shows that
PC1 mRNA and protein remain unchanged in the ARC of lean
and DIO rats. For CPE, mRNA was unchanged, but its protein
level showed a tendency to decrease. In contrast, PC2 protein
levels were significantly lower (53.1%) in the DIO ARC com-
pared with controls, yet there was no difference in PC2 mRNA
levels between lean and DIO rats. These data suggest that PC2,
which is an enzyme critical for the conversion of ACTH to
-MSH, is the key regulator of-MSH levels inDIO.Therefore,
in the next series of studies, we focused mainly on PC2.
ER Stress Is Established in the ARC of DIO Animals—The
above results prompted us to ask the following question. If
POMC mRNA does not change in the DIO condition, what
mechanism(s) could affect POMC biosynthesis/processing
such that-MSHproduction is decreased?One important pos-
sibility is the development of ER stress. As described in the
Introduction, recent studies have linked ER stress, obesity, and
dysregulation of appetite-regulating hormones (39–41). For
example, DIO in mice causes hypothalamic ER stress, which in
turn contributes to leptin resistance (39).We therefore investi-
gated whether DIO rats present ER stress in two hypothalamic
brain regions important for appetite control, the ARC and
FIGURE 2. Leptin action on POMC, ACTH, and-MSH in DIO rats. For leptin experiments, fasted animals were without food for 48 h, and leptin was infused
icv (3.5 g/rat). Black bars, lean; gray bars, DIO. For C and D, AG490 (54 nmol/rat; gray bars) or vehicle control (black bars) was infused icv. A, RT-PCR of POMC
mRNA levels. B, ACTH RIA analyses in lean andDIO ARC. C,-MSH RIA analyses in lean andDIO ARC.D, ACTH response to AG490 in lean andDIO ARC. E,-MSH
response to AG490 in lean and DIO ARC. n 12 lean and 8 DIO (A–D). Data are mean S.E. (error bars). *, p 0.05; **, p 0.01 versus lean fed vehicle (A–C) or
lean vehicle (D and E); #, p 0.05; ##, p 0.01 versus fasted within the same group (lean or DIO).
Endoplasmic Reticulum Stress Impairs POMC Processing
JUNE 14, 2013•VOLUME 288•NUMBER 24 JOURNAL OF BIOLOGICAL CHEMISTRY 17679
 at Brown University on June 22, 2013http://www.jbc.org/Downloaded from 
PVN. We focused on one of the branches of ER stress that is
activated in the mouse hypothalamus during high fat feeding
and leptin resistance (39, 42). The results show that ER stress
markers p-PERK and p-eIF2were significantly elevated in the
ARC of DIO animals compared with controls (Fig. 4, A and B).
In contrast, p-PERK and p-eIF2 levels were similar in the PVN
of DIO and lean control rats (data not shown). These results
demonstrate that ER stress developed in the ARC but not the
PVN of rats subjected to 12 weeks of HFD. We further investi-
gated whether ER stress in the ARC of lean animals could be
induced pharmacologically in a manner similar to that
observed in theDIO state. To this end, lean ratswere icv infused
with tunicamycin or thapsigargin, two well known ER stress
inducers (39, 42). Both tunicamycin and thapsigargin signifi-
cantly increased p-PERK and p-eIF2 levels in the ARC (Fig. 4,
C and D). Once it was established that DIO causes ER stress to
develop in theARCof our rats, we thendeterminedwhether the
negative leptin regulators SOCS3 and PTP1B were affected by
ER stress. Tunicamycin and thapsigargin each increased
SOCS3 mRNA (Fig. 4E) as well as SOCS3 and PTP1B proteins
in the ARC (Fig. 4F). Taken together, these results indicate that
ER stress occurs in the DIO ARC and that ER stress plays a role
in increasing negative leptin regulators.
ER Stress Impairs POMC Processing—We then determined
that inducing ER stress impairs POMC processing. For exam-
ple, we found that, when ER stress was induced in the ARC
using tunicamycin, there was a 150% increase in the ACTH/-
MSH ratio, indicating that the catalytic activity of PC2 was
markedly reduced (Fig. 5, A and B, and Table 1). This was con-
sistent with the lower PC2 protein levels seen in theARCof rats
kept on HFD feeding for 12 weeks (Fig. 3D). In addition, PC2
protein, but not mRNA, was significantly lower in the ARC of
lean rats treated with either tunicamycin or thapsigargin to
induce ER stress (Fig. 5, C andD) compared with controls. Our
results demonstrate that when ER stress is induced, either by
obesity or a pharmacological agent, both -MSH and PC2 are
significantly attenuated. Furthermore, pharmacologically
induced ER stress tended to decrease oxygen consumption and
significantly increased plasma glucose (Fig. 5, E and F), indicat-
ing a shift to a positive energy balance.
We next determined whether ameliorating the UPR acti-
vated by ER stress in DIO animals could reverse the DIO-in-
duced reduction of the POMC-derived peptides ACTH and
-MSH. Consequently, we treated both lean and DIO rats for 2
dayswithTUDCA,which is a chemical chaperone that has been
used to successfully alleviate ER stress in rats (44). We found
that TUDCA reduced p-eIF2 in the DIO ARC (Fig. 6A) and
that TUDCA rescued the decrease in both ACTH and -MSH
in DIO rats (Fig. 6, B andC), indicating that ER stress is respon-
sible for the reduction in these peptides in the DIO condition.
We also found that DIO rats gained more weight than lean
controls over this 2-day time period, but this was not the case
for DIO rats treated with TUDCA. TUDCA-treated DIO rats
gained less weight than vehicle-treatedDIO rats. In fact, weight
gain in TUDCA-treated DIO rats was similar to lean rats (Fig.
6D). Food intake significantly decreased and oxygen consump-
tion tended to increase inDIO rats treatedwith TUDCA (Fig. 6,
E and F) Fasting glucose levels tend to be higher in ourDIO rats,
FIGURE 3.POMCprocessing is altered inDIO.A, the POMCprocessing cascade ismodeled here andhas beendescribedpreviously. Black bars, lean; gray bars,
DIO. B, Western blot of PC1 protein levels in lean and DIO ARC. C, RT-PCR of PC1mRNA levels in lean and DIO ARC.D, Western blot of PC2 protein levels in lean
andDIOARC. E, RT-PCR of PC2mRNA levels in lean andDIOARC. F, Western blot of CPE protein levels in lean andDIOARC.G, RT-PCR of CPEmRNA levels in lean
and DIO ARC. Depicted analyses were performed on n 8 lean and 8 DIO (A–D) (B, D, and Fwere repeated n 8 with the same results. Data are mean S.E.
(error bars). *, p 0.05 versus lean control.
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FIGURE4.DIOandpharmacologically inducedERstress increasesp-PERKandSOCS3andPTP1Bexpression.Blackbars, lean;graybars, DIO. Protein levels
were analyzed by Western blot. A, p-PERK protein levels in lean and DIO ARC. B, p-eIF2 protein levels in lean and DIO ARC. For C–F, ER stress inducers
thapsigargin (thaps; 10 ng/rat; dark gray bars) or tunicamycin (tunic; 10g/rat; light gray bars) were icv infused in lean rats and comparedwith vehicle controls
(black bars). C, p-PERK protein levels in the ARC of lean rats treatedwith tunic or vehicle control.D, protein levels of p-eIF2 in the ARC of lean rats treatedwith
tunicamycin, thapsigargin, or vehicle control. E, analysis of SOCS3 expression by end point PCR in the ARC of lean rats treated with tunicamycin, thapsigargin,
or vehicle control. F, SOCS3 and PTP1B protein levels in the ARC of lean rats treated with tunicamycin, thapsigargin, or vehicle control. n 12 lean and 8 DIO
(A–D and F) n 3 (E). Data are mean S.E. (error bars). *, p 0.05; **, p 0.01 versus lean control (A and B) or vehicle control (C–F).
FIGURE 5. Pharmacologically induced ER stress alters ACTH, -MSH, and PC2. A–D, ER stress inducers thapsigargin (thaps; 10 ng/rat; dark gray bars) or
tunicamycin (tunic; 10 g/rat; light gray bars) were icv infused in lean rats and compared with vehicle controls (black bars). A–D, n  8/group; E and F, n 
6/group. A, RIA of ACTH peptide content in the ARC of lean rats treated with tunicamycin, thapsigargin, or vehicle control. B, RIA of -MSH peptide content in
the ARC of lean rats treated with tunicamycin, thapsigargin, or vehicle control. C, RT-PCR of PC2mRNA levels in the ARC of lean rats treated with tunicamycin,
thapsigargin, or vehicle control.D,Westernblot of PC2protein levels in theARCof lean rats treatedwith tunicamycin, thapsigargin, or vehicle control. E, fasting
glucose levels in rats treatedwith thapsigargin or vehicle control. F, oxygen consumption following thapsigargin or vehicle control infusions. Data aremean
S.E. (error bars). *, p 0.05 versus vehicle control.
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and treating these DIO rats with TUDCA tended to mitigate
that increase in fasting glucose (Fig. 6G).
In addition, this 2-day TUDCA treatment did not appear to
alter leptin signaling. For example, pSTAT3 levels were not
altered by TUDCA in either lean or DIO rats (Fig. 7A). Simi-
larly, TUDCA did not change the levels of the negative leptin
regulator SOCS3 in either lean or DIO rats (Fig. 7B). SOCS3
was elevated in DIO rats and remained elevated in DIO rats
treated with TUDCA. In addition, protein levels of the leptin
receptor OBRB were statistically similar to controls (Fig. 7C).
These data indicate that mitigating ER stress for 2 days aug-
ments ACTH and -MSH levels, which does not require
changes in leptin signaling.
Because the clearance enzyme prolylcarboxypeptidase can
regulate -MSH levels, we also measured prolylcarboxypepti-
dase in lean andDIO rats treatedwith andwithout TUDCAbut
found no differences in any comparison (diet, TUDCA, or
interaction; Fig. 7D). Furthermore, a reduction in PC2 could
affect not only the biosynthesis of -MSH but also other energy-
regulating peptides, such as neuropeptide Y (NPY) and Agouti-
related peptide (AgRP). Wemeasured NPY peptide in lean and
DIO rats treated with and without TUDCA and observed no
difference in any comparison (Fig. 7E). Most studies measure
AgRP using mRNA analyses. However, because we found
changes in the processing enzyme PC2, we wanted to measure
peptide levels. We attempted to measure AgRP peptide in lean
and DIO rats treated with and without TUDCA using the rat
AgRP ELISA kit (MBS730302) fromMyBioSource, but we were
unable to detect AgRP.
To address whether the effect of ER stress on PC2 can be
reversed by chemical chaperones specifically in POMCcells, we
pretreated N43/5 cells (a mouse hypothalamic POMC cell line
that expresses PC2) with the chemical chaperone PBA, fol-
lowed by induction of ER stress with tunicamycin. PBA has
been used successfully to moderate ER stress in a neuronal cell
line (45).We found that treatment with 0.1g/ml tunicamycin
did not change the levels of PC1 in either the presence or
absence of PBA (data not shown). These results are consistent
with the in vivo results in which PC1 levels in the ARC are
similar between lean and DIO rats (Fig. 3B). In contrast, tuni-
camycin significantly reduced PC2 levels at 2, 3, and 4 h of
treatment (Fig. 8A). Furthermore, the ER stressmarker p-eIF2
increasedwith tunicamycin treatment (Fig. 8A). These PC2 and
p-eIF2 observations in N43/5 cells subjected to ER stress
FIGURE 6.Changes inACTHand-MSH inDIOare reversedwith a chemical chaperone. Lean andDIO ratswere treatedwith (gray bars) andwithout (black
bars) the chemical chaperone TUDCA (200 mg/kg for 2 days). LV, lean vehicle (n 4); LT, lean TUDCA (n 4); DV, DIO vehicle (n 5); DT, DIO TUDCA (n 5).
A, TUDCA reduced p-eIF2 in the ARC of DIO rats. B, RIA of ACTH peptide content in the ARC of lean and DIO rats treated with and without TUDCA. C, RIA of
-MSHpeptide content in the ARCof lean andDIO rats treatedwith andwithout TUDCA.D, bodyweight of lean andDIO rats treatedwith andwithout TUDCA.
Animalswereweighed immediately prior to the first TUDCA infusion and a second time immediately prior to sacrifice.Weightwasmeasured as thepercentage
weight gain (g) from the first to the second measurement. E, TUDCA reduced food intake in DIO rats. F, oxygen consumption in DIO rats following TUDCA or
vehicle control infusions. G, fasting glucose levels in rats treated with TUDCA or vehicle control. Data are mean S.E. (error bars). *, p 0.05 versus vehicle
control.
TABLE 1
Molar ratio of ACTH/-MSH and POMC content in the ARC of lean rats
treated with the ER stress inducer tunicamycin or vehicle control
Rats treated with tunicamycin or vehicle were euthanized, and the ARC was col-
lected for HPLC and RIA analyses of POMC, ACTH, and -MSH. The first row
depicts the molar ratio of ACTH/-MSH and the percentage increase detected in
tunicamycin-treated rats. The second row depicts POMC content (pmol) and the
amount of POMC content (pmol) accumulated in tunicamycin-treated rats.
Vehicle Tunicamycin Change
ACTH/-MSH 1.4 2.1 150% increase
POMC 0.035 0.05 2-Fold accumulation
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mimic the data observed in the DIO ARC as well as in the ARC
of animals treated with tunicamycin and thapsigargin. When
cells were pretreated with PBA, PC2 levels did not decrease
compared with untreated control cells, and p-eIF2 was resis-
tant to tunicamycin treatment, indicating that ER stress reduced
PC2 (Fig. 8A). In addition, the ER stress inducer thapsigargin
also decreased PC2 in N43/5 cells. Because pharmacological
agents such as tunicamycin and thapsigargin affect cellular pro-
cesses other than ER stress, we also used salubrinal in our stud-
ies because salubrinal specifically inhibits the dephosphory-
lation of p-eIF2. We first ran a dose response, and found that
enhancing the phosphorylation of eIF2 with salubrinal
increased PC2 levels (Fig. 8B). We then found that salubrinal
reversed the effect of thapsigargin on PC2 (Fig. 8C).
Using the N45/5 neuronal POMC-positive cell line, we next
determined whether ER stress affected PC2 transcription or
caused changes in the processing of PC2 itself, because the
active form of the enzyme is the smaller, processed form that
acts in secretory granules to cleave the ACTH peptide to gen-
erate -MSH. Therefore, we measured PC2 promoter activity
in N43/5 cells treated with and without tunicamycin. Tunica-
mycin did not alter PC2 promoter activity (Fig. 8D) or PC1
activity as expected (data not shown). These results indicate
that the mechanism by which ER stress reduces PC2 occurs
after transcription, which supports our in vivo finding that PC2
mRNA in DIO rats is similar to that in lean rats (Fig. 3E). Thus,
we also tested whether the 7B2 peptide, a facilitator of PC2
maturation (46), was affected by ER stress. Fig. 8E shows that
tunicamycin did not alter the level of pro7B2 (27 kDa) or its
smaller active form of 21 kDa, suggesting that 7B2 peptide does
not participate in the down-regulation of PC2 activity during
ER stress. Consistent with the results seen in the N43/5 cells,
DIO rats did not show changes in 7B2 compared with lean rats
(Fig. 8F). Data from lean and DIO rats show that PC2 effects on
POMCprocessing are nutrient-dependent (Fig. 3D) and are not
likely to be driven by changes in transcription (Fig. 3E) or pro-
cessing (Fig. 8F). Instead, the attenuation of PC2 during ER
stress is probably caused by reduced translation efficiency or
enhanced clearance of unfolded PC2 by the ER-associated deg-
radation system or by a combination of both processes.
To corroborate our results using N45/5 cells, we also evalu-
ated the affect of ER stress on PC2 in AtT-20 cells, which are
corticotropic cells that express POMC. Furthermore, AtT20 is
the only cell line to our knowledge in which both PC2 and
-MSH can be measured if PC2 is transfected. Induction of ER
stress in these cells with thapsigargin (using conditions that
have been shown to induce ER stress in previous studies (47))
decreased PC2, but pretreatment with PBA prevented this
effect (Fig. 9A). Similar results were observed for -MSH
release (Fig. 9B).We also found that enhancing PC2 expression
in thapsigargin-treated cells overcame the effect of ER stress on
PC2 levels (Fig. 9C). Additionally, we measured the release of
-MSH into themedium and found the same pattern that thap-
sigargin decreased -MSH, but enhanced PC2 overexpression
in thapsigargin-treated cells significantly increased -MSH
compared with thapsigargin with less PC2 (Fig. 9D).
DISCUSSION
In this study, we demonstrate that there is a direct link
between ER stress and POMC processing in the obesity state
and that ER stress mediates the HFD-induced changes in
POMC processing. We show that ER stress is the mechanism
FIGURE 7. There were no changes detected in leptin signaling, prolylcarboxypeptidase (PRCP), or NPY due to TUDCA. Lean and DIO rats were treated
with (gray bars) andwithout (black bars) the chemical chaperone TUDCA (200mg/kg for 2 days). LV, lean vehicle (n 4); LT, lean TUDCA (n 4);DV, DIO vehicle
(n 5); DT, DIO TUDCA (n 5). A, Western blot of pSTAT3 protein levels in the ARC of lean and DIO rats treated with and without TUDCA. B, Western blot of
SOCS3 protein levels in the ARC of lean and DIO rats treated with and without TUDCA. C, Western blot of ObRb protein levels in the ARC of lean and DIO rats
treatedwith andwithout TUDCA.D, Western blot of PRCP protein levels in the ARC of lean andDIO rats treatedwith andwithout TUDCA. E, RIA of NPY content
in the ARC of lean and DIO rats treated with and without TUDCA. Data are mean S.E. (error bars). *, p 0.05 versus vehicle control.
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affecting POMC processing, which results in lower -MSH
production independent of POMC mRNA levels. In addition,
we demonstrate that PC2, the key specific enzyme involved in
the conversion of ACTH to -MSH, is most likely responsible
for the reduced processing of the -MSH precursor.
Obesity is associated with hypothalamic leptin resistance,
which contributes tomaintaining obesity despite hyperleptine-
mia. The importance of leptin regulation of POMC neurons
was demonstrated in earlier studies, where deletion of the lep-
tin receptor (LepR) specifically in POMCneurons (POMC-Cre:
LepRloxP/loxP) resulted in increased body weight and adiposity,
hyperleptinemia, and altered hypothalamic neuropeptide
expression (48). Early work suggested that an improvement of
ER function and leptin signaling could be achieved by adminis-
FIGURE 8. ER stress attenuates PC2 protein (but not PC2 promoter activity or processing) specifically in POMC-positive N43/5 neuronal cells, and
salubrinal-enhanced p-eIF2 increases PC2 and appears to protect against the ER stress decrease in PC2. A, PC2 and p-eIF2 protein in POMC-positive
N43/5 cells treatedwith tunicamycin (tunic; 0.1g/ml; gray bars) andwith andwithout PBA (20mM, 14 h) pretreatment. n 6; results were replicated in three
independent experiments. B, dose-response curve for PC2 protein in N43/5 cells treated with vehicle, 7.5 g of salubrinal, and 30 g of salubrinal. p-eIF2 is
also shown. n 4/group. C, PC2 protein in N43/5 cells pretreatedwith vehicle (VV), pretreatedwith vehicle then thapsigargin (thaps; for 6 h) (VT), or pretreated
with 7.5gof salubrinal (14 h) and then thapsigargin (6 h) (ST). p-eIF2 is also shown. n 6/group.D, PC2 promoter activitywith andwithout tunicamycin (1.5
h) treatment as analyzed by luciferase assay. n 8. E, Western blot analysis of 7B2 in control (white bars) and tunicamycin-treated (0.1 g/ml, 2 h; gray bars)
N43/5 cells. F, Western blot analysis of 7B2 in the ARC of lean (white bars) and DIO (gray bars) animals. E and F, n 6–9. Data aremean S.E. (error bars). *, p
0.05; **, p 0.01; ***, p 0.001 versus vehicle control at time 0 (A), vehicle (B and D), vehicle/vehicle (C), or lean controls (F).
FIGURE 9.PC2protein and-MSH releasedecreaseswith inductionof ER stress inPOMC-positiveAtT20 cells.PC2protein (A) and-MSH release into the
medium (B) in AtT20 cells pretreated with vehicle (VV), pretreated with vehicle and then thapsigargin (thaps for 6 h) (VT), or pretreated with 20mM PBA (14 h)
and then thapsigargin (6 h) (PT). PC2 protein (C) and -MSH release into the medium (D) in AtT20 cells transfected with 2 g of PC2 cDNA and treated with
vehicle, transfectedwith 2g of PC2 cDNA and treatedwith thapsigargin, or transfectedwith 4g PC2 cDNA and treatedwith thapsigargin (all n 5/group).
*, p 0.05; **, p 0.01; ***, p 0.001 versus vehicle/vehicle (A and B) or PC2 (2 g)/vehicle (C and D). #, p 0.05 versus vehicle/thapsigargin (A and B) or PC2
(2 g)/thapsigargin (C and D). Error bars, S.E.
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trating chemical chaperones in DIO animals (39). Our results
are consistent with that paradigm, showing an increase in the
phosphorylation of ER stress markers, PERK, and eIF2, which
were also activated by pharmacological induction of ER stress
in lean rats (Fig. 4). We extended these findings and showed
that the negative regulators of leptin signaling, SOCS3 and
PTP1B, are up-regulated in lean rats treated with either tunica-
mycin or thapsigargin compared with controls, which is con-
sistent with previous in vitro studies demonstrating that PTP1B
is increased during ER stress (49, 50) and contributes to ER
stress-induced leptin resistance (50). The effect of ER stress on
SOCS3 has been less clear, with one study reporting that the
N-terminal truncated isoform of SOCS3, resulting from alter-
native translation initiation, significantly increased with ER
stress through the induction of p-eIF2 (51). Overall, in vivo
results from our studies and others indicate that ER stress
occurs in DIO and contributes to leptin resistance. The up-reg-
ulation of SOCS3 and PTP1B by DIO-induced ER stress may
override the leptin signaling demand for more POMC produc-
tion in obesity, preventing an increase in POMCmRNA in the
DIO condition even with hyperleptinemia. Furthermore, it is
possible that elevated SOCS3 during ER stress and DIO condi-
tions contributes to a decrease in particular proteins, poten-
tially including PC2, by targeting these proteins for proteo-
somal degradation through polyubiquitination (52).
Early ER stress studies were an important turning point in
our understanding of ER stress and leptin resistance. The cur-
rent work described here represents a significant and novel
advance concerning the role of ER stress on prohormone pro-
cessing. Together, results indicate that ER stress affects cellular
events such as POMC processing and that these changes in
POMCprocessing do not require changes in leptin signaling. In
our studies, two bioactive POMC products, ACTH and -
MSH, are lower in DIO rats experiencing ER stress compared
with lean controls, which is a phenomenon that cannot be
attributed to changes in leptin signaling that would affect
POMC mRNA because we observe no changes in POMC
mRNA inDIO comparedwith lean rats. Although some studies
have reported that POMC mRNA decreases in DIO rodents
(53, 54), most studies do not demonstrate lower POMCmRNA
in DIO versus lean rodents (9, 55–58). In contrast to mecha-
nisms that would regulate POMC mRNA, we discovered that
ER stress-induced attenuation of the anorexigenic-MSHpep-
tide is due to a post-translational mechanism. We first estab-
lished that ACTH and -MSH are reduced when the ARC is
under ER stress due to DIO or pharmacological induction. We
further confirmed that the reduction in these POMC-derived
peptides seen in DIO is specifically caused by ER stress because
levels of these peptides are rescued after treatment with the
chemical chaperon TUDCA. Thus, enhancing the folding
capacity of the ER in obese rats, a physiological obesity model
similar to humans, can restore the potent appetite suppressor
-MSH to levels similar to those seen in lean individuals.
It is well known that leptin regulates POMCmRNA and thus
-MSHproduction and that leptin resistance contributes to the
obese condition (59, 60). Our data reveal that inhibition of
STAT3 signaling fails to suppress -MSH production in the
DIO conditions, which supports the hypothesis that leptin
resistance affects -MSH in DIO. It has also been reported that
ER stress established in DIO contributes to leptin resistance
(39). Because we do not detect any change in POMCmRNA in
the ARC of our DIO rats, it is unlikely that ER stress-induced
effects on leptin’s actions onPOMCgene expression contribute
to the decrease in -MSH in DIO. It is possible, however, that
ER stress effects on leptin sensitivity regulate -MSH levels
indirectly. AsOzcan et al. (39) demonstrated previously, chem-
ical chaperones can sensitize rodents to leptin. Thus, we tested
whether the TUDCA-induced increase in ACTH and -MSH
in our DIO rats was due to enhanced leptin signaling. However,
we detected no changes in leptin signaling molecules in the
ARC of our TUDCA-treated rats. This is probably because we
treated them with TUDCA for 2 days, whereas animals in
the previous study were given TUDCA for longer periods of
time, including TUDCA pretreatment regimes. Thus, it
appears that treatment with TUDCA for 2 days is sufficient to
reverse the DIO-induced attenuation of ACTH and -MSH as
well as to reduce weight gain, decrease food intake, and slightly
increase energy expenditure in the DIO condition but not to
improve the leptin resistance established in the DIO ARC. We
detected a slight, albeit not significant, decrease in ObRb in the
ARC of our TUDCA-treated DIO rats, suggesting that longer
term treatmentwould probably affect leptin sensitivity, as dem-
onstrated by Ozcan et al. (39), and thus potentially alter
-MSH.However, data from the current study indicate that it is
possible to rescue the changes in ACTH and -MSH during
DIO by mitigating ER stress, and this does not require changes
in leptin signaling. Future studies will characterize the role of
leptin resistance during ER stress and DIO in regulating
-MSH and other energy-regulating peptides.
Our studies pharmacologically inducing ER stress in lean
animals strongly support the hypotheses that ER stress is the
mechanism driving the reduction of post-translational POMC
processing in DIO. For example, there was a 150% increase in
the ACTH/-MSH ratio in tunicamycin-treated rats, indicat-
ing that the conversion of ACTH to -MSH was markedly
reduced. Induction of ER stress by icv thapsigargin in the cur-
rent study resulted in downstream metabolic changes, includ-
ing increased fasting glucose levels and a tendency toward
decreased energy expenditure. We also show that PC2, but not
PC1 or CPE, protein levels are significantly reduced under both
conditions, although there was a tendency for CPE to decrease
inDIO.Aprevious study demonstrated a significant decrease in
CPE mRNA in the DIO mouse (61), but we detected only a
slight decrease in CPE protein expression in our DIO rats. This
discrepancy in the magnitude of change in CPE may be due to
species differences. In early studies, we showed that leptin up-
regulates both PC1 and PC2 via STAT3 signaling (62). How-
ever, the slight increase in STAT3 signaling during DIO failed
to increase PC1 or override the reduction in PC2, suggesting
that leptin does not influence -MSH levels in DIO by affecting
POMC-processing enzymes. Our in vivo results were comple-
mented by studies using POMC-positive N43/5 and AtT20
cells, in which ER stress significantly decreased PC2. Further
experiments demonstrated that ER stress specifically reduces
PC2 because pretreatment with the chemical chaperone PBA
prevented the ER stress-induced attenuation of PC2. Similarly,
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ER stress reduced the amount of -MSH released into the
medium, and pretreatment with a chemical chaperone partially
rescued the effect. Salubrinal, which selectively inhibits the
dephosphorylation of p-eIF2 subunit  (63), has been shown
to enhance the FFA-induced activation of the PERK pathway
but not theATF6 and IRE1 branches (64).We found that block-
ing the dephosphorylation of eIF2 with salubrinal increased
PC2 and reversed the effect of thapsigargin on PC2 levels in our
POMC-positive N43/5 cells, suggesting that this aspect of the
UPR could protect the decrease in PC2 during ER stress. Fur-
thermore, enhanced expression of PC2 in cells experiencing ER
stress increased both PC2 protein levels and -MSH levels
comparedwith cells under ER stress with less PC2. Collectively,
the results indicate that the effect of obesity-induced ER stress
on -MSH biosynthesis is specific and that ER stress-mediated
attenuation of PC2 is primarily responsible for the reduced
-MSH observed in DIO rats. Fig. 10 depicts the proposed
model by which ER stress affects POMC biosynthesis and pro-
cessing in the obese state.
This is the first study, to our knowledge, to demonstrate that
ER stress alters neuropeptide processing. A previous study
demonstrated that palmitic acid impedes the processing of pro-
insulin as well as PC2 and PC1 in the pancreatic beta cell line
MIN6 (65). Because palmitic acid has been shown to elicit ER
stress and theUPR (66), it is possible that ER stress caused these
physiological changes. Furukawa et al. (65) showed that reduc-
tion of PC2 might have been due to impaired processing of the
PC2 facilitator 7B2. However, we found no difference in 7B2
levels in DIO or in N43/5 cells subjected to tunicamycin. Our
results suggest that ER stress does not mediate changes in PC2
mRNA because neither DIO nor pharmacological induction of
ER stress altered PC2mRNA.However, it is difficult tomeasure
PC2 mRNA expression specifically in POMC neurons because
theARCcontains a heterogeneousmixture of POMCandNPY/
AgRP cells that have opposing actions on food intake are both
regulated by PC2 at the intracellular level (67–69). Thus, we
also analyzed PC2 promoter activity in N43/5 POMC-positive
cells and found no effect of tunicamycin, which further sup-
ports the idea that ER stress does not alter PC2 mRNA. Given
our PC2 mRNA and our 7B2 results, it appears that ER stress
does not control ARC PC2 transcription or processing. Thus,
lower PC2 levels during ER stress are probably due to dimin-
ished translation efficiency and/or enhanced clearance of mis-
folded PC2 to the ER-associated degradation system. Future
research will investigate these possibilities and whether obesity-
induced ER stress affects processing of prohormones other
than POMC, such as proAgrp and proNPY.
Interestingly, we observed an accumulation of POMC pro-
tein in DIO compared with lean rats despite the decrease in
POMC-derived peptides. Professional secretory cells, such as
POMC neurons, have an enhanced capacity to store large
amounts of proteins/peptides and as suchmay bemore suscep-
tible to accumulation of these proteins/peptides during ER
stress than other cell types. We propose that during DIO, there
is an accumulation of unfolded proteins (including POMC) in
the ER of ARC cells, which activates the UPR. The UPR
increases p-PERK, which phosphorylates eIF2 to then inhibit
translation. eIF2 phosphorylation is essential to attenuate
translation when the protein-folding load in the ER exceeds the
protein-folding capacity. However, long term ER stress in the
DIO conditionmay lead to excess unfolded POMC that collects
in the ER, potentially exacerbating the ER stress phenomenon
and resulting in less properly packaged POMC precursor for
transit and processing. This may explain why we observe less
ACTH in DIO despite unaltered POMC mRNA and PC1.
Although beyond the scope of the current study, the next gen-
eration of this work will explore in detail the changes in POMC
folding during obesity-induced ER stress. Recent evidence
reveals that pancreatic beta-cell function is dependent on
translation inhibition by p-eIF2 during HFD (43). In this
FIGURE 10.Model depicting the changes in POMC, its processing enzyme PC2, and-MSH under conditions of fasting (i.e. low leptin; first panel), fed
(i.e.basal leptin; second panel), andDIO (i.e.high leptin; third panel). Comparedwith the fed (basal leptin) condition, fasting causes diminished-MSH by
leptin-mediated reduction in POMC mRNA along with reduced POMC processing due to lower PC1 and PC2 levels. In the DIO state, ER stress triggers an
unfolded response causing an accumulation of POMC in the ER partly caused by an unfolded response and a possible degradation of PC2 through the
ER-associated degradation system, conditions that ultimately cause less -MSH production.
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study, attenuation of p-eIF2, achieved by using amousemodel
in which an alanine was substituted for the serine 51 phosphor-
ylation site, led to accumulation of insulin in the ER, beta-cell
failure, and type 2 diabetes. Here, the data indicate that the
increase in p-eIF2 after 12 weeks of HFD is not sufficient to
counterbalance the accumulation of POMC in the ER.
Understanding the central control of energy-regulating neu-
ropeptides during DIO is important for the identification of
therapeutic targets to prevent and/or mitigate obesity pathol-
ogy. Our data have determined that obesity-induced ER stress
impairs the production of the anorexigenic neuropeptide
-MSH by affecting its precursor POMC in a post-transcrip-
tional manner. In particular, the processing of POMC is
impaired by ER stress that develops in the DIO condition. This
mechanism appears to be highly specific, primarily affecting the
enzyme PC2, which, within the POMC processing cascade, is
essential for converting ACTH to -MSH. Overall, the data
indicate that ER stress regulates POMC processing and that
PC2 is a major player in this regulation.
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